Alto Ingredients vs Sensient Technologies
ALTO and SXT side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ALTO and SXT compare
Sensient Technologies is the larger company, worth 17 times as much as Alto Ingredients ($5.1B against $298M).
On earnings, Alto Ingredients is cheaper: it trades at 6.1× trailing earnings, against 29.9× for Sensient Technologies.
Sensient Technologies grew revenue faster over the last twelve months (9.5% versus 4.1% for Alto Ingredients).
Sensient Technologies keeps more of each dollar of sales as profit, with a net margin of 9.7% compared with 5.3% at Alto Ingredients.
Sensient Technologies pays a dividend yielding 1.0%; Alto Ingredients does not pay one.
Sensient Technologies scores higher on the StockData Score (14 against 13 for Alto Ingredients), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ALTO | SXT |
|---|---|---|
| Size and price | ||
| Market cap | $298M | $5.1B |
| Share price | $3.84 | $118.81 |
| Change, 1 year | 137% | 27.9% |
| Change, 5 years | −24.9% | 15.8% |
| Beta (5Y) | 0.70 | 0.83 |
| Employees | 390 | 4,070 |
| StockData Score | ||
| Total score | 13 | 14 (better) |
| Valuation score | 4 (better) | 0 |
| Growth score | 2 | 4 (better) |
| Performance score | 3 | 4 (better) |
| Health score | 4 (better) | 3 |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 6.1× (better) | 29.9× |
| P/S | 0.3× (better) | 2.9× |
| P/B | 1.1× (better) | 3.9× |
| EV/EBITDA | 6.4× (better) | 18.3× |
| P/FCF | 8.0× | – |
| FCF yield | 12.5% (better) | −0.35% |
| Fair value | $10.63 | $95.56 |
| Margin of safety | 63.9% (better) | −24.3% |
| Growth | ||
| Revenue growth (TTM) | 4.1% | 9.5% (better) |
| Revenue growth, 5Y average | 0.46% | 3.9% (better) |
| Net income growth (TTM) | – | 21.7% |
| EPS growth (TTM) | – | 21.4% |
| EPS growth, 5Y average | – | 4.1% |
| Profitability | ||
| Gross margin | 5.8% | 35.1% (better) |
| Operating margin | 2.7% | 14.5% (better) |
| Net margin | 5.3% | 9.7% (better) |
| FCF margin | 3.9% (better) | −1.0% |
| Return on equity | 20.5% (better) | 13.7% |
| Return on invested capital | 6.8% | 10.0% (better) |
| Financial health | ||
| Debt / equity | 0.20 (better) | 0.61 |
| Net debt / EBITDA | 0.60 (better) | 2.36 |
| Interest coverage | 3.2× | 8.0× (better) |
| Current ratio | 3.39 | 3.97 (better) |
| Altman Z-score | 1.61 | 5.16 (better) |
| Piotroski F-score | 7 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | – | 1.0% |
| Payout ratio | – | 41.2% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | 1.0% |
| Shareholder yield | 0.00% | 1.0% (better) |
| Ownership | ||
| Held by institutions | 46.3% | 99.0% |
| Held by insiders | 9.2% | 26.0% |
| Insider net buying, 12 months | $361K (better) | −$234M |
| Short interest, % of float | 7.0% | 3.1% |
Go deeper
- ALTO stock overview
- ALTO income statement
- ALTO valuation and score
- SXT stock overview
- SXT income statement
- SXT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.